Regarding treatment characteristics (Table 3 ), the p value of dose reduction was marginally significant, with a lower value in the 2018–2019 group.
← all excerpts
Decreased febrile neutropenia during inpatient chemotherapy for urologic cancer during coronavirus disease 2019 pandemic.
1
—
—